These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35862417)

  • 1. Estimating the effects of legalizing recreational cannabis on newly incident cannabis use.
    Montgomery BW; Roberts MH; Margerison CE; Anthony JC
    PLoS One; 2022; 17(7):e0271720. PubMed ID: 35862417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the public health impacts of legalizing recreational cannabis use in the United States.
    Hall W; Lynskey M
    Addiction; 2016 Oct; 111(10):1764-73. PubMed ID: 27082374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between Local Jurisdiction Ordinances and Current Use of Cannabis Products in California Adolescents.
    Rogers CJ; Steinberg JK; Vos RO; Soto DW; Unger JB
    Subst Use Misuse; 2022; 57(3):373-379. PubMed ID: 34903134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newly incident cannabis use in the United States, 2002-2011: a regional and state level benchmark.
    Leinweber JP; Cheng HG; Lopez-Quintero C; Anthony JC
    PeerJ; 2017; 5():e3616. PubMed ID: 28761794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-level policy responses to state marijuana legalization in Washington State.
    Dilley JA; Hitchcock L; McGroder N; Greto LA; Richardson SM
    Int J Drug Policy; 2017 Apr; 42():102-108. PubMed ID: 28365192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six policy lessons relevant to cannabis legalization.
    Shover CL; Humphreys K
    Am J Drug Alcohol Abuse; 2019; 45(6):698-706. PubMed ID: 30870053
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabis use prevalence among Baby Boomers before and after implementation of recreational retail sales in California.
    Carlson Z; Pham S; El-Sokkary J; Apollonio DE
    Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):17. PubMed ID: 35248117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study.
    Blanco C; Hasin DS; Wall MM; Flórez-Salamanca L; Hoertel N; Wang S; Kerridge BT; Olfson M
    JAMA Psychiatry; 2016 Apr; 73(4):388-95. PubMed ID: 26886046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the public health impacts of legalizing recreational cannabis use in the USA.
    Hall W; Weier M
    Clin Pharmacol Ther; 2015 Jun; 97(6):607-15. PubMed ID: 25777798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in alcohol and cigarette consumption in response to medical and recreational cannabis legalization: Evidence from U.S. state tax receipt data.
    Veligati S; Howdeshell S; Beeler-Stinn S; Lingam D; Allen PC; Chen LS; Grucza RA
    Int J Drug Policy; 2020 Jan; 75():102585. PubMed ID: 31739147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rating the comparative efficacy of state-level cannabis policies on recreational cannabis markets in the United States.
    Blanchette JG; Pacula RL; Smart R; Lira MC; Boustead AE; Caulkins JP; Kilmer B; Kerr WC; Treffers R; Naimi TS
    Int J Drug Policy; 2022 Aug; 106():103744. PubMed ID: 35636068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the effect of Colorado's recreational marijuana policy on opioid overdose rates.
    Alcocer JJ
    Public Health; 2020 Aug; 185():8-14. PubMed ID: 32505041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-state cannabis purchases in the United States.
    Wadsworth E; Hammond D
    Drug Alcohol Depend; 2020 Feb; 207():107822. PubMed ID: 31911336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the public health impacts of legalizing recreational cannabis use: the US experience.
    Hall W; Lynskey M
    World Psychiatry; 2020 Jun; 19(2):179-186. PubMed ID: 32394566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.
    Goodwin RD; Kim JH; Cheslack-Postava K; Weinberger AH; Wu M; Wyka K; Kattan M
    Addiction; 2021 Oct; 116(10):2770-2778. PubMed ID: 33730400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Incorporation of Lessons From Tobacco Control in City and County Laws Regulating Legal Marijuana in California.
    Silver LD; Naprawa AZ; Padon AA
    JAMA Netw Open; 2020 Jun; 3(6):e208393. PubMed ID: 32558915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System.
    Shi Y; Liang D
    Addiction; 2020 Oct; 115(10):1890-1899. PubMed ID: 32080937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical Cannabis and Past-Year Cannabis Use Disorder Among Adult Recreational Users in the United States: Results From a Nationally Representative Sample.
    Rubin-Kahana DS; Hassan AN; Sanches M; Le Foll B
    Front Psychiatry; 2022; 13():836908. PubMed ID: 35432009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Side Effects" Observed Within ~1-90 Days After Cannabis Onset: Epidemiological Estimates for the United States, 2004-2014.
    Alcover KC; Thompson C; Anthony JC
    Am J Addict; 2019 Nov; 28(6):465-472. PubMed ID: 31487092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic.
    Roth W; Tam M; Bi C; Kim J; Lewis J; Ho R; Apollonio DE
    Clin Toxicol (Phila); 2022 May; 60(5):632-638. PubMed ID: 34871128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.